申请人:Hoelzemann Guenter
公开号:US20080214582A1
公开(公告)日:2008-09-04
Compounds of the formula (I), in which R
1
, R
2
, R
3
, R
4
and X have the meanings indicated in claim
1
, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.
式(I)的化合物,其中R1、R2、R3、R4和X具有权利要求1所示的含义,是酪氨酸激酶,特别是TIE-2和Raf激酶的抑制剂,可用于肿瘤治疗等领域。